Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |